Neuberger Berman Group
XERS icon

Neuberger Berman Group’s Xeris Biopharma Holdings XERS Stock Holding History

Neuberger Berman Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Sell
16,630
-95
-0.6% -$607 ﹤0.01% 2220
2026
Q1 		$97K Buy
+16,725
New +$111K ﹤0.01% 2078
2018
Q3 		– Sell
-115,000
Closed -$2.18M – 1713
2018
Q2 		$2.18M Buy
+115,000
New +$2.23M ﹤0.01% 1047

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Neuberger Berman Group's XERS Position: Q2 2026 in Review

Neuberger Berman Group reduced its Xeris Biopharma Holdings (XERS) stake by 0.57% in Q2 2026, selling an estimated $607 and leaving 16,630 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

Neuberger Berman Group first reported a position in XERS in Q2 2018 and has held it in 3 quarters since. The position peaked at $2.18M in Q2 2018. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Neuberger Berman Group held 16,630 shares of Xeris Biopharma Holdings worth $132K as of Q2 2026.
  • Neuberger Berman Group sold 95 Xeris Biopharma Holdings shares in Q2 2026, an estimated $607.
  • Xeris Biopharma Holdings made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2220 holding.
  • Neuberger Berman Group first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 3 quarters since.
  • Neuberger Berman Group's Xeris Biopharma Holdings position peaked at $2.18M in Q2 2018.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.